InSilico Medicine Hong Kong Limited
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING5
READOUTS ≤12 MONTHS2
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| INS018_055 NCT05975983 |
P2 | Recruiting | Idiopathic Pulmonary Fibrosis (IPF) | 40 | 2026-02-28 |
| ISM5411 tablets NCT07265570 |
P2 | Recruiting | Ulcerative Colitis | 80 | 2027-08-15 |
| ISM6331 NCT06566079 |
P1/2 | Recruiting | Malignant Mesothelioma; Metastatic Malignant Solid Tumor | 160 | 2027-08-31 |
| ISM3412 NCT06414460 |
P1/2 | Recruiting | Locally Advanced/Metastatic Solid Tumors | 146 | 2028-03-31 |
| INS018_055 tablets NCT07687459 |
P3 | Recruiting | Idiopathic Pulmonary Fibrosis | 320 | 2029-10-30 |